Hua Ren Pharmaceutical: subsidiary's raw material drug Isoepinephrine hydrochloride granted market approval.

Huaren Pharmaceuticals announced that its wholly-owned subsidiary, Anhui Hengxing Pharmaceutical Co., Ltd., has received the "Approval Notice for Market Application of Chemical Raw Materials" for Isoproterenol Hydrochloride issued by the National Medical Products Administration. Isoproterenol Hydrochloride is a non-selective -adrenergic receptor agonist, mainly used for the treatment of cardiogenic or septic shock, complete atrioventricular block, cardiac arrest, and acute exacerbations of bronchial asthma. This approval will enrich the company's raw material product line and enhance its market competitiveness.